Received 2023-08-21
Revised 2023-08-26
Accepted 2023-08-30
Serum Calcium and Magnesium Levels in Women Presenting with Pre-eclampsia: A Systematic Review and Meta-analysis Based on Observational Studies
Arqavan Eslamzadeh 1, Seyyed Mohammad amin Kashani 2, Nasrin Asadi 3, Sina Bazmi 1, Shahla Rezaei 4,
Zeinab Karimimoghadam 5, Peyman Nowrouzi-Sohrabi 6, Reza Tabrizi 5, 7, 8
1 Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran
2 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
3 Department of Obstetrics &Gynecology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
4 Nutrition Research Center, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
5 Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
6 Razi Herbal Medicines Research Center, Department of Biochemistry, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
7 USERN Office, Fasa University of Medical Sciences, Fasa, Iran
8 Clinical Research Development Unit, Valiasr Hospital, Fasa University of Medical Sciences, Fasa, Iran
Abstract Background: Multiple studies have investigated the serum concentrations of calcium (Ca) and magnesium (Mg) in preeclampsia, but the results have been contradictory. The objective of this systematic review and meta-analysis was to examine the association between serum calcium and magnesium levels in patients with preeclampsia and those in the healthy pregnancies. Materials and Methods: A comprehensive search was conducted in various online databases, including PubMed/Medline, Scopus, Embase, Web of Sciences, and Cochrane library to identify relevant studies on Ca and Mg levels in preeclampsia up to July 2023. Inter-study heterogeneity across the included studies was assessed using the chi-square test and I2 statistic. Pooled effect size (ES) was calculated as weighted mean differences (WMDs) with corresponding 95% confidence intervals (CI). Results: A total of 76 articles (comprising 92 studies) were included, with a combined sample size of 10,482 participants (preeclampsia: n=3,991; controls: n=6,491). The random-effects model revealed significantly lower levels of calcium (WMD=-0.807 mg/dL, 95% CI: -0.983, -0.632, P<0.01) and magnesium (WMD=-0.215, 95% CI: -0.338, -0.092, P<0.01) in women with pre-eclampsia compared to the control group. However, the overall pooled WMD for calcium and magnesium levels did not significantly change when individual studies were excluded one by one. Conclusion: This meta-analysis demonstrates that the circulating levels of calcium and magnesium in patients with preeclampsia are significantly lower than those in the control group. [GMJ.2023;12:e3151] DOI:3151 Keywords: Calcium; Female; Humans; Magnesium; Pre-eclampsia; Pregnancy |
GMJ Copyright© 2023, Galen Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/) Email:info@gmj.ir |
Correspondence to: Reza Tabrizi, Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.Telephone Number: +98917-812-1178 Email Address: kmsrc89@gmail.com |
GMJ.2023;12:e3151 |
www.gmj.ir
Eslamzadeh A, et al. |
Serum Calcium and Magnesium Levels in Women with Pre-eclampsia |
2 |
GMJ.2023;12:e3151 www.gmj.ir |
Introduction
Preeclampsia is an abnormality in pregnancy characterized by an increase in blood pressure levels and change in blood trace elements levels. Preeclampsia is commonly defined by a systolic blood pressure≥140 mmHg or diastolic pressure≥90 mmHg.
Additionally, proteinuria may serve as a marker for preeclampsia when protein level in a sample of urine exceeds 30 mg/dL [1, 2]. Preeclampsia can lead to organ disorders such as brain, liver and kidney injury [3]. Countries with nutritional deficiencies, particularly in Asia and Africa, experience a higher incidence of preeclampsia, contributing to 10 percent of pregnancy-related deaths due to high blood pressure [4, 5]. Although the mechanism of preeclampsia remains unknown, some evidence suggests a relationship with placentation and endothelial disorders [3].
Underlying conditions, including diabetes, hypertension and obesity are risk factors for preeclampsia [6]. Studies have indicated an association between preeclampsia and placental ischemia, leading to alterations in certain biomarkers and growth factors. For example, the plasma placental growth factor (PlGF) to sFlt-1 ratio is known to be altered in preeclampsia patients compared to healthy women [7]. Recent studies have presented conflicting findings regarding the relationship between serum levels of calcium (Ca) and magnesium (Mg) and preeclampsia. Winarno, Gatot N. Adhipurnawan et al, discovered that patients with preeclampsia exhibit significantly lower levels of Ca and Mg in their serum compared to healthy women [8].
Similarly, RKD Ephraime et al, reported similar results in both patients and the control group [9].
However, Golmohammad lou et al reported no significant difference between the two study groups [10]. To the best of our knowledge, no systematic review or meta-analysis has been conducted on this topic before. The aim of this study is to assess the levels of magnesium and calcium in preeclampsia patients and healthy pregnant women to discovering any relationship between alterations in trace elements and the risk of developing preeclampsia, and the severity of the disease.
Materials and Methods
The current systematic review and meta-analysis were previously registered in PROSPERO under the code CRD42021251265.
Search Strategy
We conducted a comprehensive search of online databases, including PubMed/Medline, Scopus, Embase, Web of Sciences, and Cochrane library, to identify relevant articles from their inception up to July 2023. The search strategy utilized MeSH terms and keywords as follows: ("Pre-Eclampsia» OR “Pre-eclampsia” OR «Preeclampsia» OR “Pregnancy Toxemia” OR “Edema-Proteinuria-Hypertension Gestosis” OR “Edema Proteinuria” OR “Hypertension Gestosis” OR “Hypertension-Edema-Proteinuria Gestosis” OR “Hypertension Edema Proteinuria Gestosis” OR “Toxemia Of Pregnancy” OR “Toxemia of Pregnancies” OR “EPH Complex” OR”EPH Toxemias” OR “EPH Toxemia” OR “EPH Gestosis” OR “Preeclampsia Eclampsia 1” OR “Preeclampsia Eclampsia 1s” OR “Proteinuria-Edema-Hypertension Gestosis” OR “Proteinuria Edema Hypertension Gestosis” OR Toxemia OR “Pre-eclamptic Toxaemia” OR “Pre-eclamptic Toxemia” OR “Preclampsia Preeclamptic Toxaemia” OR “Preeclamptic Toxemia” OR “Pregnancy-Induced Hypertension” OR "Eclampsia» OR «Eclampsias» OR “HELLP Syndrome” OR “Syndrome HELLP” OR “Hypertension Pregnancy” OR “Hypertemsion Preeclampsia” OR “Gestational Hypertension” OR “Postpartum Hypertension-Preeclampsia” OR “Pregnancy-Related Hypertensive Disorders” OR “Toxemia in Pregnancy” OR “Hypertension in Pregnancy” OR “High Blood Pressure in Pregnancy” OR “Gestational Proteinuric Hypertension”) AND ("Magnesium» OR «Mg2+» OR «Mg» OR “Magnesium Compounds” OR "Romag» OR «Magnesium Sulfate» OR «Magnesium Supplementation» OR «Magnesium Sulphate» OR «Mg Longoral» OR «Sulfamag» OR «Sulmetin» OR «Sulmetine» OR «Epsom Salt» OR «Epsom Salts» OR «Magnesium Sulphate in Dextrose 5” OR “Ca(2+) Mg(2+)-ATPase” OR “Mg2+-ATPase” OR “Mg2+ ATPase” OR “Mg2+-Dependent ATPase” OR “Mg2+ Dependent ATPase” OR “Calcium Magnesium ATPase” OR “Ca Mg-ATPase” OR “Ca Mg ATPase” OR “Ca2+-Mg2+ ATPase” OR “Ca2+ Mg2+ ATPase” OR “Calcium Magnesium Adenosine Triphosphatase” OR “Calcium Magnesium Adenosine Triphosphatase” OR “Magnesium Adenosine Triphosphatase” OR “Magnesium ATPase” OR “Magnesium Hydroxide” OR “Magnesium Hydrate” OR “Magnesium Deficiencies” OR “Magnesium Deficiency” OR “Magnesium Phosphate” OR “Magnesium Hydrogen Phosphate” OR “Magnesium Phosphate” OR «Magnesium Carbonate» OR «Magnesite» OR «Anhydrous Magnesium Carbonate» OR «Magnesium Carbonate Anhydrous» OR «Mg++» OR «Magnesium Ion» OR «Mg Ion» OR «Magnesium GTP» OR "Mg GTP» OR «Magnesium GTP” OR "Magnesia» OR “Magnesium Oxide” OR “Magnesium Chloride” OR «MgCl2» OR «Calcium» OR «Ca2+» OR «Ca» OR “Blood Coagulation Factor IV” OR “Coagulation Factor IV” OR «Calcium-40» OR “Calcium 40” OR “Factor IV” OR “Calcium Isotopes” OR “Calcium Radioisotopes” OR «Hypercalcemia» OR «Hypocalcemia» OR «40Ca» OR “Calcium Content” OR “Calcium Deposition” OR “Calcium Regulating Agents” OR “Calcium-Regulating Hormones and Agents” OR “Calcium Deposition”). To enhance the sensitivity of our search strategy, we also performed a manual search using the Google Scholar search engine and reviewed the reference lists of included studies and previous reviews.
Inclusion and Exclusion Criteria
We included all observational studies conducted in humans and published in English that met the following criteria: 1) included pregnant women of any gestational age; 2) compared serum calcium or magnesium levels between two groups (group 1: women presenting with pre-Eclampsia, group 2: women with a healthy pregnancy); and 3) reported at least one of the outcomes of interest related to calcium or magnesium.
We excluded studies such as previous review articles, case reports, case series, in vitro, in vivo studies, letters to the editor, commentaries, abstracts without full text, or studies with insufficient data.
Data Extraction
Two investigators (A.E & Z-K.M) independently extracted relevant data, including participant and outcome characteristics, using an Excel software spreadsheet for data abstraction. A third author (Sh.R) cross-checked the data to ensure accuracy. The extracted information included author names, study location, publication year, study method, sample size (in pre-eclamptic and healthy pregnant women), main participants’ characteristics, mean maternal age (in pre-eclamptic and healthy pregnant women), and key outcome data on mean and standard deviation (SD) of calcium and magnesium levels in both groups. Co-variables such as gestational age and body mass index (BMI) were also extracted. In some cases, articles were extracted multiple times due to the availability of subset data.
Risk of Bias (Quality) Assessment
Two investigators (A.E. and P.N.) independently assessed the quality of the included studies using the Newcastle-Ottawa Scale, which evaluates selection, comparability, and exposure/outcome aspects. Studies with a Newcastle-Ottawa Scale score of ≥5 for cross-sectional designs or a score of 7 or higher for case-control or cohort designs were considered to have good study quality (Suppl. Table-1s).
Statistical Analysis
The mean changes in serum calcium and magnesium levels in women with pre-eclampsia were estimated by calculating the weighted mean differences (WMDs) and 95% confidence intervals (CIs). Effect sizes were pooled using a random-effects model with the DerSimonian-Laird method for the meta-analysis. Heterogeneity among studies was assessed using Cochran’s Q and I-square tests. A Cochran’s Q test P-value of less than 0.1 and I-square value above 50% indicated significant heterogeneity. Sensitivity analysis was performed to evaluate the influence of individual studies on the final results. Publication bias among the included studies will be assessed using the Egger test and visual funnel plots. All statistical analyses were conducted using STATA software version 16.0 (Stata Corp., College Station, TX).
Results
Characteristics of Included Studies
Figure-1 illustrates the PRISMA flowchart depicting the step by step literature search and study selection process. After removing irrelevant and duplicate studies, we obtained the full-text papers of 159 articles out of 5104 for further evaluation based on the inclusion criteria. Among these, 83 articles did not adequately address the desired outcome and were therefore excluded. Ultimately, the meta-analysis was conducted based on 76 eligible articles (comprising 92 studies) [1, 2, 5, 11-82]. Of these, 61studies were designed as case-control studies, 27 utilized a cross-sectional design, and 4 employed a cohort design. These studies included data from 10,482 pregnant women, with 3,991 in the pre-eclampsia group and 6,491 in the healthy pregnant women group. The included articles were published between 1984 and 2023. The key characteristics of these studies are summarized in Table-1.
Meta-analysis Outcomes
Based on the inclusion of 71 and 64 studies, respectively, the meta-analysis results, using a random-effects model, for the association between calcium and magnesium levels with pre-eclampsia are depicted in Figure-2A-B. The pooled analysis demonstrates a significant decrease in the levels of calcium (WMD=-0.807 mg/dL, 95% CI: -0.983, -0.632, P<0.01) and magnesium (WMD=-0.215, 95% CI: -0.338, -0.092, P<0.01) in women with pre-eclampsia compared to controls. Considering the observed heterogeneity among the included studies, a sensitivity analysis was conducted. However, excluding individual studies one by one did not result in any significant changes in the overall pooled WMD for calcium and magnesium levels.
Publication Bias
The funnel plots displaying calcium and magnesium levels are shown in Figure-3A-B. Statistical confirmation using Egger’s tests revealed no evidence of publication bias, as indicated by P-values of 0.63 and 0.25 for calcium and magnesium levels, respectively.
Discussion
To the best of our knowledge, this is the first systematic review and meta-analysis to assess the relationship between serum calcium (Ca) and magnesium (Mg) levels and preeclampsia. The results of our study demonstrated that patients with preeclampsia had significantly lower levels of calcium (WMD=-0.807 mg/dL, 95% CI: -0.983, -0.632, P<0.01) and magnesium (WMD=-0.215, 95% CI: -0.338, -0.092, P<0.01) compared to the healthy control group. Recent studies have also reported alterations in some trace elements in preeclampsia. Our findings support the concept that serum calcium and magnesium levels are lower in preeclampsia compared to the healthy control group. Ephraim et al conducted a study involving 380 pregnant women and reported high blood pressure and lower serum levels of calcium and magnesium in preeclampsia patients [25].
Similarly, El-Maghraby et al recently revealed that both magnesium and calcium levels were decreased in preeclampsia patients [83]. Various theories have been proposed to explain the relationship between trace elements, particularly calcium and magnesium, and preeclampsia. The first theory is that some trace elements such as Ca and Mg can help alleviate oxidative stress by scavenging free radicals. Endothelial damage by oxidative stress is a key factor in the occurrence of preeclampsia. According to this, Ca and Mg have inevitable role in prevention of preeclampsia [84]. The second theory is that lower intake of calcium and magnesium is linked to increased blood pressure and the risk of preeclampsia due to the stimulation of hormonal system. The balance between calcium and magnesium serum levels is crucial for blood pressure control [5, 85].
The third theory is that intracellular calcium concentration is increased in preeclampsia due to enhancement of absorbance by cells and the level of serum calcium is decreased, disturbance in the balance of intracellular and serum level of calcium lead to vasoconstriction and hypertension during pregnancy [43]. Therefore, it is important to maintain a balance in both serum and intracellular levels of Ca and Mg.
In conclusion, the prescription of calcium and magnesium supplements or multivitamins is recommended during pregnancy, especially for women at high risk of preeclampsia [86]. According to previous reports, the mean serum magnesium and total calcium levels in preeclampsia patients were 0.70±0.15 and 2.13±0.30 mmol/L, respectively, while in healthy pregnancies they were 0.76±0.14 and 2.13±0.35 mmol/L, respectively [87]. Due to endothelial dysfunction in preeclampsia, it is important to consider the role of interleukins and other inflammatory cytokines, which can be explored in future studies.
Conclusion
In conclusion, our study, along with recent evidence, highlights the association between altered blood pressure and decreased levels of magnesium and calcium in preeclampsia. We found that the mean serum levels of magnesium and calcium were lower in patients with preeclampsia compared to the healthy control group. However, further studies are needed to investigate the levels of all trace elements in preeclampsia.
Acknowledgment
This article received approval from the Ethics Committee of Fasa Medical University with codeIR.FUMS.REC.1400.145 and was supported by The Deputy of Research and Technology of Fasa University of Medical Sciences, Fasa, Iran, with grant number 400164.
Conflict of Interest
The authors declare no conflict of interest.
Serum Calcium and Magnesium Levels in Women with Pre-eclampsia |
Eslamzadeh A, et al. |
GMJ.2023;12:e3151 www.gmj.ir |
3 |
Eslamzadeh A, et al. |
Serum Calcium and Magnesium Levels in Women with Pre-eclampsia |
4 |
GMJ.2023;12:e3151 www.gmj.ir |
Figure 1. PRISMA flow diagram to study section
Serum Calcium and Magnesium Levels in Women with Pre-eclampsia |
Eslamzadeh A, et al. |
GMJ.2023;12:e3151 www.gmj.ir |
5 |
Table 1. Characteristics of Included Studies
Authors (Publication year) |
Country |
Study type |
Sample size (Case/control) |
Body mass index (case) |
Body mass index (control) |
gestational age in case (weeks) |
gestational age in control (weeks) |
Maternal age in case (years) |
Maternal age in control (years) |
Quality Assessment |
||||||
mean |
SD |
mean |
SD |
mean |
SD |
mean |
SD |
mean |
SD |
mean |
SD |
|||||
Hamedanian et al. (2019) [88] |
Iran |
Case-control |
60/60 |
27.9 |
4.9 |
24.3 |
3.9 |
32.4 |
4.4 |
34.5 |
4.8 |
31.5 |
5.3 |
29 |
5.3 |
8 |
Abbasalizadeh et al. (2019) [1] |
Iran |
Case-control |
52/51 |
31.9 |
5 |
28.9 |
4.7 |
|
|
|
|
30.8 |
6.3 |
30.2 |
7.1 |
7 |
Ambad et al. (2020) [89] |
India |
Cross-sectional |
100/100 |
|
|
|
|
|
|
|
|
|
|
|
|
6 |
Chaudhari et al. (2018) [18] |
Nepal |
Cross-sectional |
37/37 |
29.3 |
5.4 |
24.1 |
3.7 |
36 |
2.9 |
31.2 |
4.3 |
26.7 |
5.4 |
25.9 |
4.9 |
6 |
Babacan et al. (2011) [90] |
Turkey |
Cohort |
34/11 |
|
|
|
|
34.3 |
3.7 |
37.5 |
1.1 |
30.5 |
6.1 |
30 |
5.8 |
8 |
Dogan et al. (2021) [91] |
Turkey |
Case-control |
42/46 |
24.6 |
3.2 |
24.3 |
3.1 |
36.5 |
2.4 |
38.8 |
0.9 |
31.7 |
5.9 |
31.5 |
5.3 |
7 |
Farzin et al. (2012) [27] |
Iran |
Case-control |
60/60 |
27.1 |
3.2 |
26.8 |
2.2 |
35.5 |
1.1 |
35.3 |
1.2 |
27.4 |
3.9 |
26.7 |
3.7 |
8 |
Elmugabil et al. (2016) [24] |
Sudan |
Case-control |
50/50 |
29 |
5 |
27 |
5.1 |
37.1 |
1 |
36.8 |
1 |
28.6 |
6.4 |
28.6 |
6.6 |
7 |
Hashemipour et al. (2017) [92] |
Iran |
Case-control |
74/75 |
|
|
|
|
|
|
|
|
|
|
|
|
8 |
Golmohammad Lou et al. (2008) [10] |
Iran |
Case-control |
52/52 |
21.6 |
50 |
21.4 |
51 |
35.2 |
0.8 |
36.7 |
1.1 |
25.7 |
1.2 |
22.7 |
1.5 |
8 |
Alghazali et al. (a) (2014) [93] |
Iraq |
Case-control |
31/50 |
28.7 |
2.1 |
27.1 |
2.2 |
|
|
|
|
26.5 |
6.5 |
25.0 |
5.5 |
7 |
Alghazali et al. (b) (2014) [93] |
Iraq |
Case-control |
19/50 |
30.3 |
3.9 |
27.1 |
2.2 |
|
|
|
|
28.5 |
6.7 |
25.0 |
5.5 |
7 |
M. E. Gunes et al. (2021) [28] |
Turkey |
Case-control |
40/40 |
33.1 |
4.8 |
28.9 |
3.5 |
37.0 |
1.3 |
38.3 |
0.9 |
30.0 |
8.2 |
25.9 |
4.7 |
7 |
B. Adam et al. (2001) [11] |
Turkey |
Case-control |
20/20 |
|
|
|
|
35 |
4 |
37 |
3.9 |
29 |
8 |
27 |
6.8 |
8 |
Continues on next page |
Eslamzadeh A, et al. |
Serum Calcium and Magnesium Levels in Women with Pre-eclampsia |
6 |
GMJ.2023;12:e3151 www.gmj.ir |
Continue of Table 1. Characteristics of Included Studies
L. Poonia et al. (2021) [64] |
India |
Cross-sectional |
100/100 |
24.5 |
3.7 |
22.3 |
2.9 |
|
|
|
|
|
|
|
|
5 |
Ahsan et al. (2013) [12] |
Bangladesh |
Cross-sectional |
44/27 |
|
|
|
|
35.6 |
3.8 |
36.2 |
2.6 |
26.1 |
5.4 |
24.1 |
4.9 |
6 |
S. Akhtar et al. (2011) [13] |
Bangladesh |
cross sectional |
60/30 |
25.8 |
2.4 |
23.3 |
2.1 |
32.3 |
3.5 |
31.5 |
3.9 |
25.1 |
5.7 |
25.2 |
4.9 |
6 |
Al-Rubaye et al. (a) (2009) [14] |
Iraq |
Cross-sectional |
30/30 |
|
|
|
|
|
|
|
|
|
|
|
|
5 |
Al-Rubaye et al. (b) (2009) [14] |
Iraq |
Cross-sectional |
30/30 |
|
|
|
|
|
|
|
|
|
|
|
|
5 |
R. Aziz et al. (2014) [15] |
Pakistan |
Case-control |
16/16 |
|
|
|
|
32.3 |
4.8 |
32.9 |
5.8 |
24.7 |
17 |
25.6 |
58.9 |
8 |
Borekci et al. (2009) [16] |
Turkey |
Case-control |
24/16 |
|
|
|
|
34.3 |
1.3 |
33.8 |
1.5 |
30.9 |
7.7 |
27.5 |
5.5 |
6 |
E. O. Darkwa et al. (2017) [20] |
Ghana |
cross sectional |
30/30 |
32.0 |
7.5 |
30.5 |
5.5 |
|
|
|
|
30.9 |
5.5 |
29.9 |
2.6 |
6 |
B. Das et al. (2014) [21] |
India |
Case-control |
40/40 |
|
|
|
|
31.2 |
4.1 |
33 |
4.4 |
25.9 |
3.4 |
26.5 |
2.8 |
8 |
A Dhungana et al. (2017) [23] |
Nepal |
Case-control |
35/35 |
|
|
|
|
|
|
|
|
|
|
|
|
5 |
Talat J. Hassan et al. (1991) [29] |
Pakistan |
Case-control |
50/100 |
|
|
|
|
36 |
3 |
36 |
3 |
22 |
3 |
22 |
3 |
7 |
E. S. Idogun et al. (2007) [30] |
Nigeria |
Cross-sectional |
11/23 |
|
|
|
|
|
|
|
|
32 |
5.3 |
33 |
5.7 |
6 |
I. C. Ikechukwu et al. (2012) [31] |
Nigeria |
Cohort |
59/150 |
29.4 |
4.6 |
27.6 |
3.7 |
35.5 |
2 |
39 |
1.6 |
27.3 |
3.2 |
26.7 |
3.6 |
6 |
S. Jain et al. (a) (2009) [34] |
India |
Case-control |
25/50 |
|
|
|
|
34.9 |
3.5 |
33.6 |
7.8 |
23.0 |
3.8 |
23.9 |
3.4 |
7 |
S. Jain et al. (b) (2009) [34] |
India |
Case-control |
25/50 |
|
|
|
|
35.1 |
3.6 |
33.6 |
7.8 |
22.9 |
3.8 |
23.9 |
3.4 |
7 |
Continues on next page |
Serum Calcium and Magnesium Levels in Women with Pre-eclampsia |
Eslamzadeh A, et al. |
GMJ.2023;12:e3151 www.gmj.ir |
7 |
Continue of Table 1. Characteristics of Included Studies
B. Jamal et al. (2017) [35] |
Pakistan |
Cross sectional |
40/40 |
25.3 |
0.4 |
23.5 |
0.3 |
35.3 |
0.4 |
36.8 |
0.3 |
25.8 |
0.7 |
25.5 |
0.8 |
6 |
D. V. Kanagal et al. (2014) [36] |
India |
Case-control |
60/60 |
27.1 |
3.1 |
24.9 |
2.3 |
36.9 |
0.9 |
38.2 |
0.8 |
27.5 |
4.3 |
25.9 |
3.1 |
8 |
MK Kashyap et al. (2006) [37] |
India |
Case-control |
100/100 |
|
|
|
|
34.3 |
3.7 |
38.3 |
1.2 |
25.9 |
3.7 |
25.4 |
2.4 |
7 |
O. Katz et al. (2012) [39] |
Israel |
Case-control |
43/80 |
|
|
|
|
37.7 |
2.6 |
38.2 |
2.2 |
27.2 |
7.1 |
30.3 |
5.7 |
7 |
J. Kim et al. (2012) [42] |
Korea |
Case-control |
29/30 |
24 |
5.8 |
21.3 |
3.3 |
34.1 |
3 |
39.1 |
1.1 |
32.1 |
4.6 |
31.9 |
3.1 |
8 |
K. Kisters et al. (2000) [43] |
Germany |
Case-control |
16/18 |
|
|
|
|
35.2 |
2.1 |
33.8 |
2.4 |
28.8 |
6.7 |
27.8 |
5 |
7 |
K. Kisters et al. (1998) [45] |
Germany |
Case-control |
20/25 |
|
|
|
|
34.9 |
2 |
33.6 |
2.2 |
27.5 |
6.3 |
28.7 |
5.1 |
7 |
K. Kisters et al. (1990) [49] |
Germany |
Case-control |
27/22 |
|
|
|
|
35.1 |
2.2 |
33.7 |
2.3 |
27.3 |
6.1 |
29.6 |
4.7 |
7 |
M. Kosch et al. (2000) [50] |
Germany |
Case-control |
16/18 |
|
|
|
|
35.2 |
2.1 |
33.8 |
2.4 |
28.8 |
6.7 |
27.8 |
5 |
7 |
S. Kumru et al. (2003) [51] |
Turkey |
Case-control |
30/30 |
|
|
|
|
|
|
|
|
26.7 |
5.3 |
28 |
4.9 |
7 |
H. Lal et al. (1995) [53] |
India |
Case-control |
25/25 |
|
|
|
|
|
|
|
|
|
|
|
|
7 |
J. Masse et al. (a) (1993) [55] |
Canada |
Cohort |
109/1116 |
23.9 |
5.3 |
21.8 |
3.3 |
17.4 |
1.8 |
17.6 |
1.7 |
25.5 |
4.3 |
26.2 |
4.2 |
6 |
J. Masse et al. (b) (1993) [55] |
Canada |
Cohort |
109/1136 |
|
|
|
|
29.1 |
1.2 |
29.3 |
1.5 |
|
|
|
|
6 |
S. Mittal et al. (2014) [56] |
India |
Case-control |
100/100 |
|
|
|
|
|
|
|
|
|
|
|
|
8 |
K. Nahar et al. (2010) [57] |
Bangladesh |
cross sectional |
20/60 |
|
|
|
|
35 |
20.1 |
38 |
18.4 |
25.4 |
6.2 |
25.3 |
4.3 |
5 |
C. E. M. Okoror et al. (2020) [59] |
Nigeria |
Case-control |
27/54 |
|
|
|
|
33.4 |
3.9 |
33.5 |
3.6 |
32.1 |
6.5 |
32.2 |
6.1 |
8 |
Continues on next page |
Eslamzadeh A, et al. |
Serum Calcium and Magnesium Levels in Women with Pre-eclampsia |
8 |
GMJ.2023;12:e3151 www.gmj.ir |
Continue of Table 1. Characteristics of Included Studies
E. B. Pedersen et al. (1984) [63] |
Denmark |
Case-control |
15/18 |
|
|
|
|
|
|
|
|
|
|
|
|
7 |
C. Punthumapol et al. (a) (2008) [65] |
Thailand |
cross sectional |
35/36 |
34.5 |
6.2 |
27.9 |
5.5 |
36.3 |
3.2 |
38.3 |
1.9 |
29.1 |
8.0 |
25.6 |
6.9 |
6 |
C. Punthumapol et al. (b) (2008) [65] |
Thailand |
cross sectional |
33/36 |
27.3 |
8.9 |
27.9 |
5.5 |
36.2 |
3.6 |
38.3 |
1.9 |
25.6 |
7.0 |
25.6 |
6.9 |
6 |
D. G. D. Richards et al. (2013) [67] |
South Africa |
Case-control |
96/96 |
28.6 |
8.4 |
28.4 |
8.4 |
20.9 |
6.5 |
21.8 |
6.8 |
24 |
4.3 |
24 |
4.4 |
7 |
S. R. Richards et al. (a) (1984) [68] |
America |
Case-control |
20/16 |
|
|
|
|
35 |
|
38 |
|
|
|
|
|
6 |
S. R. Richards et al. (b) (1984) [68] |
America |
Case-control |
11/16 |
|
|
|
|
34 |
|
38 |
|
|
|
|
|
6 |
M. Rostami et al. (2011) [69] |
Iran |
cross sectional |
35/35 |
|
|
|
|
|
|
|
|
|
|
|
|
4 |
R. Sanders et al. (a) (1999) [70] |
Netherlands |
Case-control |
15/6 |
|
|
|
|
32 |
4.3 |
13 |
1.8 |
28.7 |
5.2 |
31.2 |
6.2 |
7 |
R. Sanders et al. (b) (1999) [70] |
Netherlands |
Case-control |
15/10 |
|
|
|
|
32 |
4.3 |
26.2 |
3 |
28.7 |
5.2 |
29.8 |
7 |
7 |
R. Sanders et al. (c) (1999) [70] |
Netherlands |
Case-control |
15/18 |
|
|
|
|
32 |
4.3 |
33.9 |
2.5 |
28.7 |
5.2 |
31.1 |
4.7 |
7 |
C. A. Saputri et al. (a) (2020) [71] |
Indonesia |
Cross-sectional |
30/30 |
|
|
|
|
|
|
|
|
|
|
|
|
5 |
C. A. Saputri et al. (b) (2020) [71] |
Indonesia |
Cross-sectional |
12/30 |
|
|
|
|
|
|
|
|
|
|
|
|
5 |
P. P. Sende et al. (2019) [72] |
Nigeria |
Cross-sectional |
90/90 |
|
|
|
|
36.4 |
2.5 |
36.2 |
2.3 |
28.7 |
5.2 |
28.3 |
5.1 |
6 |
C. Standley et al. (a) (1997) [73] |
America |
Case-control |
9/22 |
|
|
|
|
|
|
|
|
|
|
|
|
7 |
C. Standley et al. (b) (1997) [73] |
America |
Case-control |
9/22 |
|
|
|
|
|
|
|
|
|
|
|
|
7 |
Continues on next page |
Serum Calcium and Magnesium Levels in Women with Pre-eclampsia |
Eslamzadeh A, et al. |
GMJ.2023;12:e3151 www.gmj.ir |
9 |
Continue of Table 1. Characteristics of Included Studies
C. Standley et al. (c) (1997) [73] |
America |
Case-control |
9/22 |
|
|
|
|
|
|
|
|
|
|
|
|
7 |
K. Sukonpan et al. (2005) [75] |
Thailand |
Case-control |
40/40 |
30.2 |
4.3 |
27.3 |
3.7 |
37.1 |
3 |
38.2 |
2 |
28.4 |
4.7 |
27 |
4.8 |
8 |
Z. Tavana et al. (2013) [76] |
Iran |
Cross-sectional |
26/52 |
|
|
|
|
33.4 |
3.2 |
34.2 |
3.6 |
28.3 |
4.6 |
27.2 |
4.5 |
6 |
I. C. Udenze et al. (a) (2014) [78] |
Nigeria |
Case-control |
50/50 |
|
|
|
|
|
|
|
|
|
|
|
|
7 |
I. C. Udenze et al. (b) (2014) [78] |
Nigeria |
Case-control |
50/50 |
|
|
|
|
|
|
|
|
|
|
|
|
7 |
T. Fadhillah et al. (2021) [94] |
Indonesia |
Cross-sectional |
40/40 |
26.7 |
5.3 |
22.7 |
3.2 |
32.6 |
5.1 |
37.5 |
1.2 |
30.5 |
6.8 |
33.1 |
4.9 |
5 |
M. I. Khattak et al. (2021) [40] |
Pakistan |
Case-control |
40/40 |
31.1 |
2.0 |
28.7 |
2.1 |
|
|
|
|
27.8 |
4.2 |
28.2 |
4.9 |
7 |
D. D. Jain et al. (2021) [33] |
India |
Case-control |
50/50 |
|
|
|
|
|
|
|
|
24.5 |
2.8 |
23.8 |
3.2 |
8 |
Kuye-Kuku TO et al. (2023) [52] |
Nigeria |
Case-control |
60/60 |
|
|
|
|
|
|
|
|
|
|
|
|
8 |
I. K. P. Isong et al. (2022) [32] |
Nigeria |
Cross-sectional |
30/30 |
33.4 |
6.6 |
30.3 |
3.6 |
|
|
|
|
28.7 |
5.3 |
30 |
5.4 |
6 |
M. Chauhan et al. (2021) [19] |
India |
Case-control |
100/100 |
|
|
|
|
|
|
|
|
26.4 |
3.6 |
25.6 |
3.9 |
8 |
S. M. N. Uddin et al. (2022) [77] |
Bangladesh |
Case-control |
74/118 |
26.7 |
2.5 |
25.6 |
1.7 |
31.0 |
6.1 |
25.9 |
5.9 |
27.5 |
8.4 |
24.6 |
5.5 |
6 |
R. Rani et al. (2022) [95] |
India |
Cross-sectional |
37/17 |
29.3 |
5.4 |
24.1 |
3.7 |
36 |
2.9 |
31.2 |
4.3 |
26.7 |
5.4 |
25.9 |
4.9 |
6 |
W. R, Abdulhaleem et al. (2022) [2] |
Iraq |
Case-control |
50/50 |
|
|
|
|
33.6 |
4.2 |
34.3 |
4.1 |
31.5 |
4.3 |
32.1 |
4.3 |
8 |
G. N. A. Winarno et al. (2021) [82] |
Indonesia |
Cross-sectional |
138/108 |
30.6 |
5.2 |
28.1 |
5.3 |
36.3 |
4.1 |
36.4 |
3.8 |
30.7 |
8.2 |
30.3 |
6.7 |
6 |
S. Parvin et al. (a) (2021) [61] |
Bangladesh |
Case-control |
40/40 |
|
|
|
|
|
|
|
|
|
|
|
|
8 |
Continues on next page |
Eslamzadeh A, et al. |
Serum Calcium and Magnesium Levels in Women with Pre-eclampsia |
10 |
GMJ.2023;12:e3151 www.gmj.ir |
Continue of Table 1. Characteristics of Included Studies
S. Parvin et al. (b) (2021) [61] |
Bangladesh |
Case-control |
40/40 |
|
|
|
|
|
|
|
|
|
|
|
|
8 |
R. D. Gebreyohannes et al. (2021) [5] |
Ethiopia |
Case-control |
42/42 |
26.2 |
3.5 |
26.1 |
4.2 |
36.7 |
3.8 |
38.5 |
3.6 |
27 |
6 |
27 |
4 |
6 |
F. F. Khidri et al. (a) (2021) [41] |
Pakistan |
Cross-sectional |
30/35 |
|
|
|
|
36.7 |
3.6 |
38.7 |
2.1 |
24.6 |
3.2 |
25.6 |
2.6 |
6 |
F. F. Khidri et al. (b) (2021) [41] |
Pakistan |
Cross-sectional |
70/35 |
|
|
|
|
36.2 |
2.8 |
38.7 |
2.1 |
24.8 |
2.2 |
25.6 |
2.6 |
6 |
B. Rashid et al. (2015) [66] |
Pakistan |
Cross-sectional |
100/100 |
|
|
|
|
35.5 |
1.8 |
36.5 |
1.3 |
26.1 |
2.6 |
25.7 |
1.8 |
6 |
S. Maksane et al. (2011) [54] |
India |
Case-control |
20/20 |
|
|
|
|
|
|
|
|
|
|
|
|
7 |
f. Vahidroodsary et al. (2007) [81] |
Iran |
Case-control |
50/50 |
|
|
|
|
|
|
|
|
24.1 |
5.2 |
27.8 |
6.4 |
5 |
J. Nnodim et al. (2017) [58] |
Nigeria |
Case-control |
100/100 |
24.9 |
2.1 |
23.8 |
2.4 |
35.2 |
3.3 |
38.8 |
4.0 |
22.5 |
3.4 |
23.5 |
3.1 |
8 |
H.Vafaei et al. (a) (2015) [80] |
Iran |
Case-control |
20/40 |
|
|
|
|
|
|
|
|
|
|
|
|
8 |
H.Vafaei et al. (b) (2015) [80] |
Iran |
Case-control |
20/40 |
|
|
|
|
|
|
|
|
|
|
|
|
8 |
j. bringman et al. (2006) [17] |
America |
Case-control |
10/10 |
|
|
|
|
|
|
|
|
|
|
|
|
5 |
M. Patwari et al. (2016) [62] |
India |
Case-control |
50/100 |
7 |
||||||||||||
O. A. Onyegbule et al. (2014) [60] |
Nigeria |
Cross-sectional |
54/48 |
29.3 |
6.0 |
27.8 |
4.3 |
27 |
7.0 |
29 |
5.4 |
6 |
||||
Ugwuja EI et al. (2016) [79] |
Nigeria |
Cross-sectional |
40/40 |
20.3 |
3.9 |
27.2 |
5.4 |
21.4 |
3.2 |
21.5 |
3.7 |
29.5 |
3.7 |
27.6 |
4.2 |
6 |
R. Sujatha et al. (a) (2015) [74] |
India |
Case-control |
40/50 |
|
|
|
|
|
|
|
|
6 |
||||
R. Sujatha et al. (b) (2015) [74] |
India |
Case-control |
10/50 |
|
|
|
|
|
|
|
|
6 |
Serum Calcium and Magnesium Levels in Women with Pre-eclampsia |
Eslamzadeh A, et al. |
GMJ.2023;12:e3151 www.gmj.ir |
11 |
Figure 2A. The forest plot of meta-analysis of the association between calcium (A) and magnesium (B) levels with pre-eclampsia.
Eslamzadeh A, et al. |
Serum Calcium and Magnesium Levels in Women with Pre-eclampsia |
12 |
GMJ.2023;12:e3151 www.gmj.ir |
Figure 2B. The forest plot of meta-analysis of the association between calcium (A) and magnesium (B) levels with pre-eclampsia.
Serum Calcium and Magnesium Levels in Women with Pre-eclampsia |
Eslamzadeh A, et al. |
GMJ.2023;12:e3151 www.gmj.ir |
13 |
Figure 3A-B. The funnel plots to visual assess of publication bias for calcium (A) and magnesium (B) levels across included studies.
Eslamzadeh A, et al. |
Serum Calcium and Magnesium Levels in Women with Pre-eclampsia |
14 |
GMJ.2023;12:e3151 www.gmj.ir |
Serum Calcium and Magnesium Levels in Women with Pre-eclampsia |
Eslamzadeh A, et al. |
GMJ.2023;12:e3151 www.gmj.ir |
15 |
References |
Eslamzadeh A, et al. |
Serum Calcium and Magnesium Levels in Women with Pre-eclampsia |
16 |
GMJ.2023;12:e3151 www.gmj.ir |
Serum Calcium and Magnesium Levels in Women with Pre-eclampsia |
Eslamzadeh A, et al. |
GMJ.2023;12:e3151 www.gmj.ir |
17 |
Eslamzadeh A, et al. |
Serum Calcium and Magnesium Levels in Women with Pre-eclampsia |
18 |
GMJ.2023;12:e3151 www.gmj.ir |
Serum Calcium and Magnesium Levels in Women with Pre-eclampsia |
Eslamzadeh A, et al. |
GMJ.2023;12:e3151 www.gmj.ir |
19 |